Structure-activity relationships of estrogens. Effects of 14-dehydrogenation and axial methyl groups at C-7, C-9 and C-11.
Thirty compounds were evaluated in the rat for uterotropic effects, inhibition of gonadotropin release, and competitive displacement of (3H) estradiol-17 beta from uterine cytosolic preparations. 7 alpha-Methylestradiol-17 beta was 150% as active as estradiol-17 beta as an uterotropic agent. Estradiol-17 beta was the most active inhibitor of gonadotropin release. 11 beta-Methylestradiol-17 beta had 124% of the activity of estradiol-17 beta in displacing (3H) estradiol-17 beta from the "estrogen receptor." The 9 alpha-methyl group considerably decreased the potency of estrogens in any of the three assays. The 14-dehydro modification was advantageous only in the estradiol-17 beta 3-methyl ether series. Uterotropic activities and inhibition of gonadotropin release did not parallel. The best compound for inhibiting gonadotropin release, as compared to uterotropic activity, was estrone. The "estrogen receptor" assay data correlated fairly well with uterotropic assay data, but only for compounds having free 3-hydroxyl groups; even so, some exceptions were noted.
D000818:Animals; D001681:Biological Assay; D003427:Cross Circulation; D004958:Estradiol / Q000031:analogs & derivatives; D004967:Estrogens / Q000138:chemical synthesis / Q000494:pharmacology*; D004970:Estrone / Q000031:analogs & derivatives; D005260:Female; D006065:Gonadotropins, Pituitary / Q000037:antagonists & inhibitors* / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D051381:Rats; D011960:Receptors, Estrogen / Q000187:drug effects; D013329:Structure-Activity Relationship; D014599:Uterus / Q000187:drug effects*
D004967:Estrogens; D006065:Gonadotropins, Pituitary; D011960:Receptors, Estrogen; D004970:Estrone; D004958:Estradiol